Navigation Links
Merck Company Foundation Announces HIV Care Collaborative with Atlanta, Houston and Philadelphia Health Departments
Date:7/19/2012

WHITEHOUSE STATION, N.J., July 19, 2012 /PRNewswire/ -- The Merck Company Foundation announces the launch of a three-year, $3 million initiative that will support the health departments in Atlanta, Houston and Philadelphia to connect more people living with HIV in these high-burden communities to the care they need to stay healthy. The initiative will be launched with program partners on Sunday, July 22, 2012 at the start of the XIX International AIDS Conference.

The HIV Care Collaborative for Underserved Populations in the United States aligns with President Obama's National HIV/AIDS Strategy's goals which include entering and retaining more patients in care and is designed to support existing programs that have the greatest potential to reduce new HIV infections.   According to the Centers for Disease Control and Prevention, 1.2 million people in the United States are living with HIV infection, with 50,000 new infections each year.  A third of Americans with known HIV infections are not receiving health care and 20 to 40 percent of patients fail to establish care within six months of receiving an HIV-positive diagnosis.

"Too many people living with HIV/AIDS are not getting the health care they need to stay healthy and contribute to healthy communities," said Geralyn S. Ritter, senior vice president, Global Public Policy & Corporate Responsibility, Merck & Co., Inc. and president, The Merck Company Foundation. "Merck has a long-standing commitment to expanding access to health care and helping respond to the HIV/AIDS epidemic, and the HIV Care Collaborative reinforces this commitment here in the United States."

Each of the selected health departments will receive up to $1 million over three years, to enhance existing efforts and foster other innovative approaches to better serve people living with HIV/AIDS and prevent its further spread.  The communities will address local provider-based an
'/>"/>

SOURCE The Merck Company Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
2. Ambrx Collaborates with Merck to Design and Develop Biologic Drug Conjugates
3. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
4. Monsanto Declared Worst Company of 2011 by NaturalSociety
5. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
6. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
7. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
8. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
9. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
10. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
11. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: ... progressing its ground-breaking technology platforms to Phase 1 clinical ... Company delivers the best value for shareholders. ... the Company currently had an extensive program of activities ... academic partnerships and initiatives, and he was working with ...
(Date:7/29/2015)... Station, TX (PRWEB) , ... July 29, 2015 ... ... POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ... to the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... , July 29, 2015  Pfenex Inc. (NYSE ... financial results will be released on Thursday, August 13, ... Eastern Time, Pfenex management will host a conference call ... update.  A press release outlining the financial results and ... call. Please call 1-866-376-8058 (US) or 1-412-542-4131 ...
(Date:7/29/2015)... ... July 29, 2015 , ... Finding gooey or crusty ... quite normal. Although there are a considerable number of terms in popular use to ... post-sleep material is a mixture of mucus, blood cells, skin cells and dust, but ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 3What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 4
... GREENVILLE, S.C., April 11 Signalife, Inc.,(Amex: SGN ... 10-KSB, and the,company,s Chairman and Chief Executive Officer, Dr. ... 2008, at 10:00 a.m. EDT., Dr. Harmison stated: ... and the Company is manufacturing and shipping,product, I am ...
... April 11 , - Newly Established Organization ... Ortho Biotech Oncology Research & Development (ORD), a ... L.L.C., will announce,results from studies of three innovative ... Association for Cancer Research (AACR),2008 Annual Meeting., ...
... 3 years confirms value of assay of cell-mediated ... ... analysis of three years,of data on the monitoring of cell-mediated immunity (CMI) ... (UCLA) Health System have demonstrated that ImmuKnow(R) values,appear to closely reflect the ...
Cached Biology Technology:Signalife Announces Webcast 2Signalife Announces Webcast 3Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 2Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 3Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 4Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 5Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection 2Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection 3
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/24/2015)... NEW YORK , June 24, 2015 ... favorable rate. The major drivers for the market include ... increasing number of new drug launches. Over the years, ... has increased. Between 2001 and 2010, the FDA approved ... addition, according to WIPO, Europe ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... With the "green" reputation of large hydroelectric dams already ... dams on rivers around the world make an important ... change. Their study, showing that more methane than previously ... appears in ACS, journal Environmental Science & Technology ...
... long since been a standard animal model for cancer research, ... average and high incidence of cancer. Naked mole rats however, ... rodent has a maximum lifespan exceeding 30 years and most ... single incident of cancer has been detected makes the naked ...
... released today a white paper detailing BioNimbus, a new patent-pending ... a package while it is moving through a 3D virtual ... of something a person is viewing, and measure biological responses, ... of optical, neural and biometric measurement. "We all ...
Cached Biology News:The naked mole-rat's secret to staying cancer free 2If you see a puppy on a package, are you more likely to buy it? 2